Silymarin (milk thistle)

DRUG2 trials

Sponsors

National Institutes of Health Clinical Center (CC), National Center for Complementary and Integrative Health (NCCIH)

Conditions

HIV InfectionHealthyHepatitis C, Chronic

Phase 1

The Effect of Milk Thistle on the Pharmacokinetics of Indinavir

CompletedNCT00011635

National Institutes of Health Clinical Center (CC)Healthy, HIV Infection

Start: 2001-02-28End: 2001-06-30Target: 20Updated: 2008-03-04

Phase 2

Evaluating Silymarin for Chronic Hepatitis C

CompletedNCT00030030

National Center for Complementary and Integrative Health (NCCIH)Hepatitis C, Chronic

Start: 2000-07-31End: 2002-06-30Updated: 2006-08-18